ERCC1 / RAD10 (Tumor Progression Marker)(ERCC1/2318), CF647 conjugate, 0.1mg/mL Antibody | BNC472318-100

(No reviews yet) Write a Review
SKU:
37-BNC472318-100
Availability:
IN STOCK
Weight:
1.00 KGS
€418.00
Frequently bought together:

Description

ERCC1 / RAD10 (Tumor Progression Marker)(ERCC1/2318), CF647 conjugate, 0.1mg/mL Antibody | BNC472318-100| Gentaur Distribution US, UK & Europe

Summary.: Recognizes a protein of 110 kDa, identified as Excision Repair Cross Complementing 1 (ERCC1). It is a mammalian nucleotide excision repair (NER) enzyme involved in repair of damaged DNA. ERCC1 is a homologous to RAD10 in Saccharomyces cerevisiae, which is required in mitotic intrachromosomal recombination and repair. ERCC1 is required in repair of cisplatin-induced DNA adducts and ultraviolet (UV)-induced DNA damage. High expression of ERCC1 has been linked to tumor progression in a variety of cancers including non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head, ovarian cancer and esophageal cancer. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors. .

Conjugate: CF647.

Storage Buffer: PBS, 0.1% BSA, 0.05% azide.

Storage Temperature: 2°C to 8°C.

Application: .

Stability: Stable at room temperature or 37°C (98°F) for 7 days.

View AllClose

Additional Information

Size:
100 uL
View AllClose